Molecular and cellular characterization of ABCG2 in the prostate

被引:48
|
作者
Pascal L.E. [1 ,2 ]
Oudes A.J. [1 ,2 ]
Petersen T.W. [2 ]
Goo Y.A. [1 ,2 ]
Walashek L.S. [1 ,2 ]
True L.D. [3 ]
Liu A.Y. [1 ,2 ]
机构
[1] Department of Urology, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle
[2] Institute for Systems Biology, Seattle
[3] Department of Pathology, University of Washington, Seattle
关键词
Side Population; Hank Balance Salt Solution; Side Population Cell; Prostate Stem Cell Antigen; Basal Epithelium;
D O I
10.1186/1471-2490-7-6
中图分类号
学科分类号
摘要
Background. Identification and characterization of the prostate stem cell is important for understanding normal prostate development and carcinogenesis. The flow cytometry-based side population (SP) technique has been developed to isolate putative adult stem cells in several human tissue types including the prostate. This phenotype is mainly mediated by the ATP-binding cassette membrane transporter ABCG2. Methods. Immunolocalization of ABCG2 was performed on normal prostate tissue obtained from radical prostatectomies. Normal human prostate SP cells and ABCG2(+ )cells were isolated and gene expression was determined with DNA array analysis and RT-PCR. Endothelial cells were removed by pre-sorting with CD31. Results. ABCG2 positive cells were localized to the prostate basal epithelium and endothelium. ABCG2(+ )cells in the basal epithelium constituted less than 1% of the total basal cell population. SP cells constituted 0.5-3% of the total epithelial fraction. The SP transcriptome was essentially the same as ABCG2(+ )and both populations expressed genes indicative of a stem cell phenotype, however, the cells also expressed many genes in common with endothelial cells. Conclusion. These results provide gene expression profiles for the prostate SP and ABCG2(+ )cells that will be critical for studying normal development and carcinogenesis, in particular as related to the cancer stem cell concept. © 2007 Pascal et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [21] Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport
    Patel, Atish
    Li, Tian-Wen
    Anreddy, Nagaraju
    Wang, De-Shen
    Sodani, Kamlesh
    Gadhia, Sanket
    Kathawala, Rishil
    Yang, Dong-Hua
    Cheng, Changmei
    Chen, Zhe-Sheng
    PHARMACOLOGICAL RESEARCH, 2017, 121 : 184 - 193
  • [22] Differential inhibition of murine Bcrpl/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C
    Gonzalez-Lobato, Lucia
    Real, Rebeca
    Prieto, Julio G.
    Alvarez, Ana I.
    Merino, Gracia
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 644 (1-3) : 41 - 48
  • [23] ABCG2 -: a transporter for all seasons
    Sarkadi, B
    Özvegy-Laczka, C
    Német, K
    Váradi, A
    FEBS LETTERS, 2004, 567 (01) : 116 - 120
  • [24] Ivermectin Interacts With Human ABCG2
    Jani, Marton
    Makai, Ildiko
    Kis, Emese
    Szabo, Pal
    Nagy, Tuende
    Krajcsi, Peter
    Lespine, Anne
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (01) : 94 - 97
  • [25] The ABCG2 resistance network of glioblastoma
    Bleau, Anne-Marie
    Huse, Jason T.
    Holland, Eric C.
    CELL CYCLE, 2009, 8 (18) : 2936 - 2944
  • [26] The Challenge of Exploiting ABCG2 in the Clinic
    Robey, Robert W.
    Ierano, Caterina
    Zhan, Zhirong
    Bates, Susan E.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (04) : 595 - 608
  • [27] Pleiotropic Effect of ABCG2 in Gout
    Merriman, Tony R.
    Phipps-Green, Amanda
    Boocock, James
    Riches, Philip
    Tausche, Anne-Kathrin
    Radstake, Timothy
    Janssen, Matthijs
    Joosten, Leo A. B.
    Jansen, Tim L.
    So, Alexander
    Hindmarsh, Jennie Harre
    Stamp, Lisa K.
    Dalbeth, Nicola
    Wrigley, Rebekah
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [28] Cellular expression and function of naturally occurring variants of the human ABCG2 multidrug transporter
    Boglárka Zámbó
    Orsolya Mózner
    Zsuzsa Bartos
    György Török
    György Várady
    Ágnes Telbisz
    László Homolya
    Tamás I. Orbán
    Balázs Sarkadi
    Cellular and Molecular Life Sciences, 2020, 77 : 365 - 378
  • [29] Purification and structural analyses of ABCG2
    McDevitt, Christopher A.
    Collins, Richard
    Kerr, Ian D.
    Callaghan, Richard
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (01) : 57 - 65
  • [30] Design of inhibitors of BCRP/ABCG2
    Juvale, Kapil
    Wiese, Michael
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (12) : 1521 - 1527